Background: Little is known about the long term prognosis for patients the severe acute motor axonal neuropathy (AMAN) form of Guillain–Barré syndrome (GBS), unlike those with acute inflammatory ...

OBJECTIVES To assess the extent of loss of myelinated nerve fibres and spinal motor neuron loss in chronic inflammatory demyelinating polyneuropathy (CIDP), a clinicopathological ... and extensive in ...

Studies now suggest that neural protein levels in serum and cerebrospinal fluid reflect axonal damage and predict poor outcome in patients with immune-mediated neuropathy, although validation ...

Some reduction in conduction velocity can be the result of axonal ... [5,6,7,8] where a demyelinating neuropathy was reported. Some diseases producing liver dysfunction can independently cause ...

The effect of alcohol consumption, severity of liver disease and encephalopathy on the incidence and severity of neuropathy were also studied. Methods: Patients having an identifiable cause of ...

Patients who begin treatment for chronic inflammatory demyelinating polyneuropathy ... and the Inflammatory Neuropathy Cause and Treatment (INCAT) Sensory Sum Score (ISS) was not statistically ...

Neuropathy is a disease that affects the nerves in the body's edges. It can cause numbness, tingling, pain, and weakness in the places that are affected. A lot of people know about familiar causes ...

About 46% of chronic alcohol users will eventually develop this condition. The exact cause of alcoholic neuropathy is unclear. However, it is known to be directly related to heavy and long-term ...

Supplements may help reverse or reduce symptoms. Some vitamin and mineral deficiencies that may cause neuropathy include: Taking too much of any supplement can cause serious health problems ...

Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...